Downloadable Resources
Access helpful resources that you can take with you on the go.
Access helpful resources that you can take with you on the go.
Discover information about OneSource patient services, including financial assistance, injection training support, frequently asked questions, and more to help you be more prepared for your treatment journey.
Read this helpful guide to understanding the insurance process for getting on treatment and learn about important access support options available to patients who have been prescribed STRENSIQ® (asfotase alfa).
STRENSIQ Injection IQ is a booklet with quick tips and tricks for injecting STRENSIQ. Learn about getting ready for your injection, preparing and giving the injection, and Important Safety Information.
Find additional tools and resources that can assist you with scheduling and provide disease education.
Dive into a collection of children's stories created by Alexion to help you explain living with a rare disease to your loved ones.
INDICATION AND IMPORTANT SAFETY INFORMATION & INDICATION
STRENSIQ® (asfotase alfa) may cause serious side effects, including:
Serious allergic (hypersensitivity) reactions happened in some people who use STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a serious allergic reaction, including
What is STRENSIQ?
STRENSIQ is a prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
Calcium buildup in the eyes and kidneys can occur if you or your loved one have HPP. Your healthcare provider should check the eyes and kidneys while you or your loved one use STRENSIQ.
Decreased efficacy. Contact your healthcare provider if you or your loved one notice STRENSIQ is no longer working or experience worsening symptoms of HPP (e.g., increased respiratory support, increased difficulty walking, new fractures).
The most common side effects of STRENSIQ include local skin injection-site reactions (red skin patches, bruising, color change, pain, itching, thinning, swelling, pits, and bumps) and calcium buildup in your eyes and kidneys.
STRENSIQ may affect other lab test results, therefore it is important that you present your Medical Alert Card to your healthcare team so they are aware that you are being treated with an alkaline phosphatase (ALP) replacement therapy which may cause incorrect results on certain laboratory tests.
Tell your doctor if you are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed.
These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. To report SUSPECTED ADVERSE REACTIONS, contact Alexion Pharmaceuticals, Inc. at 1-844-259-6783 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see STRENSIQ full Prescribing Information, including Patient Information and Instructions for Use.
STRENSIQ® (asfotase alfa) may cause serious side effects, including:
Serious allergic (hypersensitivity) reactions happened in some people who use STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a serious allergic reaction, including
Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
Calcium buildup in the eyes and kidneys can occur if you or your loved one have HPP. Your healthcare provider should check the eyes and kidneys while you or your loved one use STRENSIQ.
Decreased efficacy. Contact your healthcare provider if you or your loved one notice STRENSIQ is no longer working or experience worsening symptoms of HPP (e.g., increased respiratory support, increased difficulty walking, new fractures).
The most common side effects of STRENSIQ include local skin injection-site reactions (red skin patches, bruising, color change, pain, itching, thinning, swelling, pits, and bumps) and calcium buildup in your eyes and kidneys.
STRENSIQ may affect other lab test results, therefore it is important that you present your Medical Alert Card to your healthcare team so they are aware that you are being treated with an alkaline phosphatase (ALP) replacement therapy which may cause incorrect results on certain laboratory tests.
Tell your doctor if you are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed.
These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. To report SUSPECTED ADVERSE REACTIONS, contact Alexion Pharmaceuticals, Inc. at 1-844-259-6783 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
INDICATION:What is STRENSIQ?
STRENSIQ is a prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
Please see STRENSIQ full Prescribing Information, including Patient Information and Instructions for Use.
INDICATION
What is STRENSIQ?
STRENSIQ is a prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
INDICATION AND IMPORTANT SAFETY INFORMATION & INDICATION
STRENSIQ® (asfotase alfa) may cause serious side effects, including:
Serious allergic (hypersensitivity) reactions happened in some people who use STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a serious allergic reaction, including
Skin thickening or pits at the injection site (lipodystrophy) has happened several months after using STRENSIQ.
Calcium buildup in the eyes and kidneys can occur if you or your loved one have HPP. Your healthcare provider should check the eyes and kidneys while you or your loved one use STRENSIQ.
Decreased efficacy. Contact your healthcare provider if you or your loved one notice STRENSIQ is no longer working or experience worsening symptoms of HPP (e.g., increased respiratory support, increased difficulty walking, new fractures).
The most common side effects of STRENSIQ include local skin injection-site reactions (red skin patches, bruising, color change, pain, itching, thinning, swelling, pits, and bumps) and calcium buildup in your eyes and kidneys.
STRENSIQ may affect other lab test results, therefore it is important that you present your Medical Alert Card to your healthcare team so they are aware that you are being treated with an alkaline phosphatase (ALP) replacement therapy which may cause incorrect results on certain laboratory tests.
Tell your doctor if you are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed.
These are not all the possible side effects of STRENSIQ. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. To report SUSPECTED ADVERSE REACTIONS, contact Alexion Pharmaceuticals, Inc. at 1-844-259-6783 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
INDICATION AND IMPORTANT SAFETY INFORMATION & INDICATION
STRENSIQ® (asfotase alfa) may cause serious side effects, including:
Serious allergic (hypersensitivity) reactions happened in some people who use STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency room right away if you or your loved one have any of the signs and symptoms of a serious allergic reaction, including
What is STRENSIQ?
STRENSIQ is a prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).